- Startseite
- et-2862
- Edgar V. Lerma 🇵🇠on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇠on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
4.6 (751) · € 28.50 · Auf Lager
Thread by @edgarvlermamd: .@goKDIGO Consensus Conference on
Edgar V. Lerma 🇵🇠ಮೇಲೆ X: CKD-aP (CKD associated pruritus
Edgar V. Lerma 🇵🇠on X: FSGS ca. 2021 from @Kidney_Int @goKDIGO
Edgar V. Lerma 🇵🇠on X: The Clinical Practice Guideline for the
Edgar V. Lerma 🇵🇠on X: Membranous Nephropathy: 2 important
Edgar V. Lerma 🇵🇠on X: .@goKDIGO Controversies Conference on
Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls
Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls
Edgar V. Lerma 🇵🇠on X: .@goKDIGO Practice Point 1.1.1
Edgar V. Lerma 🇵🇠on X: Current CKD nomenclature used by
Edgar V. Lerma 🇵🇠on X: @goKDIGO @Kidney_Int Membranous
Edgar V. Lerma 🇵🇠on X: @krithicism @hswapnil @kidney_boy
Edgar V. Lerma 🇵🇠on X: .@goKDIGO Glomerular Diseases Guideline
